{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:05:59Z","timestamp":1722038759551},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Rationale:<\/jats:title><jats:p>Of all the parts of the larynx, the glottis has the highest frequency of cancer. With disease progression, the vocal cord movement is affected and for advanced stages its anatomical and functional preservation is rarely achievable, if at all.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patient concerns:<\/jats:title><jats:p>Here we describe a 72-year-old patient who presented with hoarseness for a year and was only able to whisper.<\/jats:p><\/jats:sec><jats:sec><jats:title>Diagnosis:<\/jats:title><jats:p>A computed tomography (CT) scan of the vocal cords (without contrast) showed higher density tissue. Histological examination disclosed a well-differentiated verrucous squamous cell carcinoma of the glottis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions:<\/jats:title><jats:p>The patient was treated with the oncolytic ECHO-7 virus Rigvir without any of the standard treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcomes:<\/jats:title><jats:p>As shown by CT scans, the patient has been stabilized, and the laryngeal functions are preserved with the virotherapy still ongoing. The patient was diagnosed over 4.2 years ago.<\/jats:p><\/jats:sec><jats:sec><jats:title>Lessons:<\/jats:title><jats:p>Considering the present patient being treated with Rigvir without any standard treatment, the results suggest that Rigvir therapy could be a possible treatment for glottic cancer.<\/jats:p><\/jats:sec>","DOI":"10.1097\/md.0000000000017883","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T01:40:07Z","timestamp":1573177207000},"page":"e17883","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir"],"prefix":"10.1097","volume":"98","author":[{"given":"Guna","family":"Proboka","sequence":"first","affiliation":[{"name":"Latvian Oncology Centre, Riga Eastern Clinical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnija","family":"Rasa","sequence":"additional","affiliation":[{"name":"Rigvir"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evija","family":"Olmane","sequence":"additional","affiliation":[{"name":"Department of Radiology, Pauls Stradi\u0146\u0161 Clinical University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergejs","family":"Isajevs","sequence":"additional","affiliation":[{"name":"Department of Pathology, Riga Eastern Clinical University Hospital"},{"name":"Department of Pathology, Faculty of Medicine, University of Latvia, Riga, Latvia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andra","family":"Tilgase","sequence":"additional","affiliation":[{"name":"Rigvir"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0113teris","family":"Alberts","sequence":"additional","affiliation":[{"name":"Rigvir"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,11]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1200\/JOP.2016.014225","article-title":"Multidisciplinary care of laryngeal cancer","volume":"12","author":"Salvador-Coloma","year":"2016","journal-title":"J Oncol Pract"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3322\/caac.21386","article-title":"An update on larynx cancer","volume":"67","author":"Steuer Conor","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R4-20230915","first-page":"4701","article-title":"State of the art in the treatment of laryngeal cancer","volume":"33","author":"Jenckel","year":"2013","journal-title":"Anticancer Res"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MOO.0000000000000032","article-title":"Laryngeal cancer","volume":"22","author":"Tomeh","year":"2014","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1288\/00005537-198410000-00010","article-title":"T3 glottic cancer: options and consequences of the options","volume":"94","author":"Lawrence","year":"1984","journal-title":"Laryngoscope"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/CMR.0000000000000180","article-title":"Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study","volume":"25","author":"Doni\u0146a","year":"2015","journal-title":"Melanoma Res"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2018.08.042","article-title":"The advent of oncolytic virotherapy in oncology: the Rigvir\u00ae story","volume":"837","author":"Alberts","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"23297","DOI":"10.18632\/oncotarget.4195","article-title":"The role of MicroRNAs expression in laryngeal cancer","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0360-3016(03)00511-X","article-title":"The epidermal growth factor receptor mediates radioresistance","volume":"57","author":"Liang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1017\/S0022215114003247","article-title":"Viral gene therapy for head and neck cancer","volume":"129","author":"Hughes","year":"2015","journal-title":"J Laryngol Otol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.tripleo.2011.05.021","article-title":"Oncolytic viruses: a new paradigm for treatment of head and neck cancer","volume":"113","author":"Lott","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-06-0913","article-title":"Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting","volume":"12","author":"Sok","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12254-016-0270-8","article-title":"Immunotherapy for head and neck squamous cell carcinoma","volume":"9","author":"Fuereder","year":"2016","journal-title":"Memo"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40425-016-0158-5","article-title":"Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy","volume":"4","author":"Rehman","year":"2016","journal-title":"J Immunother Cancer"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1072-7515(01)00866-3","article-title":"Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus","volume":"193","author":"Wong","year":"2001","journal-title":"J Am Coll Surg"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S0022215113003344","article-title":"Treatment modality: a predictor of continued tobacco use after treatment in patients with laryngeal cancer","volume":"128","author":"Narwani","year":"2014","journal-title":"J Laryngol Otol"},{"issue":"(Suppl 1)","key":"R19-20230915","first-page":"E2214","article-title":"Prognostic value of continued smoking on survival and recurrence rates in patients with head and neck cancer: a systematic review","volume":"38","author":"van Imhoff Lieke","year":"2015","journal-title":"Head Neck"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ajim.20605","article-title":"Occupational wood dust exposure and the risk of laryngeal cancer: a population based case-control study in Germany","volume":"51","author":"Ramroth","year":"2008","journal-title":"Am J Ind Med"},{"issue":"(Suppl 1)","key":"R21-20230915","first-page":"S56","article-title":"Primary total laryngectomy versus organ preservation for T3\/T4a laryngeal cancer: a population-based analysis of survival","volume":"41","author":"Dziegielewski","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.phrs.2008.09.007","article-title":"Defining off-label and unlicensed use of medicines for children: results of a Delphi survey","volume":"58","author":"Neubert","year":"2008","journal-title":"Pharmacol Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T13:10:30Z","timestamp":1721999430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017883"}},"subtitle":["A retrospective case report"],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":21,"journal-issue":{"issue":"45","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017883","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}